ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)Jens Hoeppner, J. R. Siewert, Peter Bronsert et al.|BMC Cancer|2016Cited by 352
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGISalah‐Eddin Al‐Batran, Stefan Paul Moenig, Thorsten Oliver Goetze et al.|BMC Cancer|2017Cited by 226